Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Financial Flexibility Index
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥160.33 Million (operating CF CN¥133.43 Million minus capex CN¥26.90 Million) represents 0% of total liabilities (CN¥2.97 Billion). Also explore 600572 net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang CONBA Pharmaceutical Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Zhejiang CONBA Pharmaceutical Co Ltd across 23 annual periods. Check Zhejiang CONBA Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Zhejiang CONBA Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600572 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | CN¥1.09 Billion | CN¥942.61 Million | CN¥2.83 Billion | ▼ -11.7% |
| 2024 | 0.44x | CN¥1.30 Billion | CN¥1.01 Billion | CN¥2.99 Billion | ▲ +53.0% |
| 2023 | 0.28x | CN¥1.11 Billion | CN¥898.64 Million | CN¥3.89 Billion | ▼ -29.0% |
| 2022 | 0.40x | CN¥1.45 Billion | CN¥1.16 Billion | CN¥3.61 Billion | ▼ -6.4% |
| 2021 | 0.43x | CN¥1.46 Billion | CN¥889.94 Million | CN¥3.40 Billion | ▼ -1.5% |
| 2020 | 0.44x | CN¥1.71 Billion | CN¥1.25 Billion | CN¥3.93 Billion | ▲ +79.2% |
| 2019 | 0.24x | CN¥1.19 Billion | CN¥925.50 Million | CN¥4.92 Billion | ▲ +29.1% |
| 2018 | 0.19x | CN¥925.41 Million | CN¥545.78 Million | CN¥4.92 Billion | ▼ -33.0% |
| 2017 | 0.28x | CN¥1.00 Billion | CN¥712.27 Million | CN¥3.58 Billion | ▼ -6.4% |
| 2016 | 0.30x | CN¥1.20 Billion | CN¥969.71 Million | CN¥4.01 Billion | ▲ +34.2% |
| 2015 | 0.22x | CN¥1.12 Billion | CN¥831.26 Million | CN¥5.00 Billion | ▼ -37.5% |
| 2014 | 0.36x | CN¥1.05 Billion | CN¥617.43 Million | CN¥2.93 Billion | ▼ -6.5% |
| 2013 | 0.38x | CN¥711.68 Million | CN¥235.36 Million | CN¥1.86 Billion | ▲ +65.1% |
| 2012 | 0.23x | CN¥485.52 Million | CN¥245.76 Million | CN¥2.10 Billion | ▼ -2.9% |
| 2011 | 0.24x | CN¥321.45 Million | CN¥188.36 Million | CN¥1.35 Billion | ▼ -25.5% |
| 2010 | 0.32x | CN¥239.00 Million | CN¥125.93 Million | CN¥747.34 Million | ▲ +20.8% |
| 2009 | 0.26x | CN¥206.72 Million | CN¥153.39 Million | CN¥780.76 Million | ▼ -4.3% |
| 2008 | 0.28x | CN¥179.67 Million | CN¥98.56 Million | CN¥649.60 Million | ▲ +18.5% |
| 2007 | 0.23x | CN¥161.81 Million | CN¥79.98 Million | CN¥693.32 Million | ▲ +7.1% |
| 2006 | 0.22x | CN¥136.87 Million | CN¥71.20 Million | CN¥628.20 Million | ▼ -47.9% |
| 2005 | 0.42x | CN¥234.22 Million | CN¥117.65 Million | CN¥560.55 Million | ▲ +34.6% |
| 2004 | 0.31x | CN¥129.28 Million | CN¥65.47 Million | CN¥416.37 Million | ▼ -0.7% |
| 2003 | 0.31x | CN¥106.98 Million | CN¥66.64 Million | CN¥342.22 Million | — |